Intravascular embolizing agent containing angiogenesis-inhibiting substance

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5202352
SERIAL NO

07740849

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an intravascular embolizing agent containing an angiogenesis-inhibiting substance and an intravascular embolizing substance. The agent strengthens the antitumor effect of an angiogenesis-inhibiting substance and serves to reduce the dose and undesirable side effects. And use of the agent in concert with an anti-neoplastic agent brings about further strong and long-lasting antitumor effects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kamei, Shigeru Takarazuka, JP 21 741
Okada, Hiroaki Suita, JP 68 3662
Yoshioka, Toshio Nishinomiya, JP 28 758

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation